These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2147469)

  • 61. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    J Clin Endocrinol Metab; 1989 May; 68(5):966-70. PubMed ID: 2715294
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral spironolactone improves acne vulgaris and reduces sebum excretion.
    Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P
    Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clascoterone for treatment of acne.
    Manjaly C; Martinez J; Barbieri J; Mostaghimi A
    Drugs Today (Barc); 2023 Feb; 59(2):71-81. PubMed ID: 36811407
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
    Turowski CB; James WD
    Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spironolactone in dermatology.
    Cunliffe WJ
    J Am Acad Dermatol; 1992 Jan; 26(1):137-8. PubMed ID: 1531055
    [No Abstract]   [Full Text] [Related]  

  • 66. Optimizing the Trial Design for a Comparative Effectiveness Study of Spironolactone versus Oral Antibiotics for Women With Acne: A Delphi Consensus Panel.
    Barbieri JS; Margolis DJ
    J Drugs Dermatol; 2020 Dec; 19(12):1238-1239. PubMed ID: 33346508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Spironolactone in adolescent acne vulgaris.
    Dhurat R; Shukla D; Lim RK; Wambier CG; Goren A
    Dermatol Ther; 2021 Jan; 34(1):e14680. PubMed ID: 33326148
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An antiandrogen in acne and idiopathic hirsutism.
    Pria SD; Greenblatt RB; Mahesh VB
    J Invest Dermatol; 1969 Apr; 52(4):348-50. PubMed ID: 4238084
    [No Abstract]   [Full Text] [Related]  

  • 69. Long-term use of spironolactone for acne in women: A case series of 403 patients.
    Garg V; Choi JK; James WD; Barbieri JS
    J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Topical antiandrogen therapy in seborrheic blepharitis].
    Prantera M; Pizzino A; Pizzino D; Varotti C
    G Ital Dermatol Venereol; 1988 Nov; 123(11):581-2. PubMed ID: 2978266
    [No Abstract]   [Full Text] [Related]  

  • 71. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.
    Barbieri JS; Choi JK; James WD; Margolis DJ
    J Am Acad Dermatol; 2019 Sep; 81(3):848-851. PubMed ID: 30905798
    [No Abstract]   [Full Text] [Related]  

  • 72. Topical spironolactone reduces sebum secretion rates in young adults.
    Yamamoto A; Ito M
    J Dermatol; 1996 Apr; 23(4):243-6. PubMed ID: 8935338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term safety of spironolactone in acne: results of an 8-year followup study.
    Shaw JC; White LE
    J Cutan Med Surg; 2002; 6(6):541-5. PubMed ID: 12219252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature.
    Barker RA; Wilcox C; Layton AM
    Am J Clin Dermatol; 2020 Apr; 21(2):303-305. PubMed ID: 32166709
    [No Abstract]   [Full Text] [Related]  

  • 75. Spironolactone for 
Adult Female Acne.
    Friedman AJ
    Cutis; 2015 Oct; 96(4):216-7. PubMed ID: 27141564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The therapeutic effect of spironolactone in the hyperandrogenism syndrome].
    Shilin DE; Dedov II; Grigor'eva EA
    Probl Endokrinol (Mosk); 1993; 39(2):55-60. PubMed ID: 8016057
    [No Abstract]   [Full Text] [Related]  

  • 77. The efficacy of Topical Clascoterone versus systematic spironolactone for treatment of acne vulgaris: A systematic review and network meta-analysis.
    Basendwh MA; Alharbi AA; Bukhamsin SA; Abdulwahab RA; Alaboud SA
    PLoS One; 2024; 19(5):e0298155. PubMed ID: 38814916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spironolactone in dermatology.
    Aguilar Medina DA; Cazarín J; Magaña M
    Dermatol Ther; 2022 May; 35(5):e15321. PubMed ID: 35038224
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hirsutism and the effectiveness of spironolactone in its management.
    McMullen GR; Van Herle AJ
    J Endocrinol Invest; 1993 Dec; 16(11):925-32. PubMed ID: 8144871
    [No Abstract]   [Full Text] [Related]  

  • 80. Importance of spironolactone in the treatment of acne in adult women.
    Saint-Jean M; Ballanger F; Nguyen JM; Khammari A; Dréno B
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1480-1. PubMed ID: 21114688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.